AlphAIalphai — Financial news for AI agents
SEC EDGARAUG 101 min read$ARCB

MCREYNOLDS JUDY R sold $397K of ARCB (indirect holdings)

MCREYNOLDS JUDY R sold 2,857 indirectly-held shares of ARCBEST CORP /TX/ (ARCB) at $138.98 ($0.40M total) on 2026-08-07.

Original reporting
SEC EDGAR · MCREYNOLDS JUDY R
Published Aug 10, 2026, 4:22 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 10, 2026, 4:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$ARCB
Neutral
low confidence
Mentioned
$ARCB
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ARCBNeutralLow
01

Why it matters

The newest fact is the disclosed open-market sale of 2,857 shares at $138.98 on 2026-08-07, with holdings after the sale of 50,048 shares.

02

Market read

Traders may note the insider sale, but there is no accompanying fundamental catalyst in the text.

03

What to watch

Insider sales can be scheduled, tax-related, or diversification-driven; without additional context, the signal-to-noise for price impact is low.

Relevance 4/10Novelty 3/10Timing: filed 2026-08-10, transaction dated 2026-08-07

Background

The article is a SEC Form 4 insider transaction disclosure for ARCBEST CORP, reported by a director.

Company-level read

Ticker impact

$ARCBNeutralLow confidence
Context

ARCBEST CORP director Judy R. McReynolds sold 2,857 shares at $138.98 via an open-market sale, indirect holdings.

Expected impact

Likely limited near-term impact; any effect is more sentiment-driven than fundamental.

Evidence & confidence

The filing is a disclosed sale by a director, but the article provides no accompanying company news, earnings, or policy change, and insider sales are often non-informational.

Market effects

Sector

No sector-level implications are provided beyond a single insider transaction.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Because the sale is indirect and lacks a stated 10b5-1 plan, it could reflect personal liquidity needs rather than bearish expectations.

Key entities

  • issuer
    ARCBEST CORP

    Company whose director insider sale is disclosed on Form 4.

  • insider
    MCREYNOLDS JUDY R

    Director who sold shares via an open-market sale; reported as indirect holdings.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ARCB insider trading history →

Related articles

AUG 5
$ARCBMed

ArcBest’s Q2 Earnings Call: Our Top 5 Analyst Questions

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, and adjusted EPS of $2.38 versus $2.26 expected. Adjusted EBITDA was $115M versus $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, with sales volumes down 2.8% YoY. Management cited pricing discipline, efficiency gains, and noted no broad industrial demand inflection.

financialcontent.com4 min
AUG 1
$ARCBMed

ARCB Q2 Deep Dive: Restructuring and Digital Initiatives Take Center Stage Amid Market Challenges

ArcBest reported Q2 revenue of $1.18B, matching analyst estimates, with adjusted EPS of $2.38 vs $2.26 and adjusted EBITDA of $115M vs $111.7M. Operating margin fell to -1.7% from 3.6% a year earlier, and sales volumes declined 2.8% YoY. The company outlined restructuring and ArcBestView digital initiatives, targeting $40M annualized cost savings and growth in managed solutions.

yahoo.com6 min
JUL 31
$ARCBMed

ArcBest Q2 Earnings Call Highlights

The company expects the initiatives to generate about $40 million in annualized cost savings. Chief Financial Officer Matt Beasley said ArcBest recognized about $2 million of savings in the second quarter and expects approximately $6 million in the third quarter. The company expects to reach the full $10 million quarterly run rate by the first quarter of 2027. About 75% of the $40 million in savings is associated with the asset-based business.

yahoo.com5 min
JUL 31
$MSFTMed

Stocks Tumble as Chipmakers Plunge, Oil Spikes

US MBA mortgage applications fell -6.4% in the week ended July 24, with the purchase mortgage sub-index down -3.6% and the refinancing mortgage sub-index down -9.9%. The average 30-year fixed rate mortgage rose +7 bp to an 11.5-month high of 6.76% from 6.69% the prior week. The outlook for strong Q2 earnings, which continue this week, is a bullish factor for stocks.

yahoo.com7 min
JUL 30
$ARCBMedAI 8/10

ArcBest’s Q2 a step on path to recovery

ArcBest's second-quarter results showed operational improvements in both of its business segments. It is benefitting from heavier shipment weights on the asset-based side of the house while cost initiatives have pushed its logistics offering back into profitability. Shipment weights increasing as TL freight returns ArcBest's (NASDAQ: ARCB) asset-based unit, which includes less-than-truckload subsidiary ABF Freight, reported a 10% y/y increase in revenue to $784 million.

yahoo.com4 min
JUL 29
$ARCBMed

ArcBest reports second quarter loss, affected by restructuring costs | Arkansas Democrat Gazette

ArcBest reported a Q2 GAAP loss of $13.8 million, or 62 cents per share, versus a year-ago profit of $25.8 million, or $1.12 per share. Revenue rose to $1.18 billion from $1.02 billion. Non-GAAP net income was $53.6 million, or $2.38 per diluted share. The results were tied to restructuring costs from a July 16 plan and included $40 million annualized savings.

arkansasonline.com6 min